The introduction of tandem mass spectrometry in the last decade has widely reduced the costs and increased the efficiency of administrative processes associated with newborn screening in the United States. As state programs have begun to overcome diagnostic, procedural, and coordinative challenges, they have been faced with a new set of public concerns over the diseases for which testing should be conducted, informed consent, privacy and the retention of blood samples for biomedical research.

Legal Cases

Legislation (Information provided by the National Conference of State Legislatures)

List of Articles, Reviews and Reports

National Conference of State Legislatures information about the scope of newborn testing programs.

National Conference of State Legislatures information about newborn screening privacy issues


For customized queries, use the Advanced Search.



Newborn Screening

Criminal Justice

Privacy and Confidentiality


Health Insurance

Life, Disability, and Long-Term Care Insurance

Medical Malpractice

Other Issues


General Information

Articles and Reviews

Case Database


Working Group